← ANALYST RATINGS · TIPRANKS
Inogen (INGN): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months · top analysts only12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $12.00, the highest $12.00, the lowest $12.00. The average is +92.0% from the last price of $6.25.
Analyst ratings 4
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $5.50 → $6.00+9.1% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $5.00 → $6.00+20.0% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $5.50 → $6.00+9.1% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $5.50 → $6.00+9.1% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $5.50 → $6.00+9.1% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $5.50 → $6.00+9.1% | Hold | −4.0% | Reiterated | 02.10.26on TipRanks 10:05 | — | |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $12.00 | Buy | +92.0% | Reiterated | 01.10.26on TipRanks 06:07 | +13.3%next day −0.9% · 5 days −2.0% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $5.50 | Hold | −12.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $5.50 → $5.00−9.1% | Hold | −20.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $5.50 | Hold | −12.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $5.00 → $5.50+10.0% | Hold | −12.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $5.50 | Hold | −12.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $5.50 | Hold | −12.0% | Reiterated | 01.10.26on TipRanks 00:05 | — | |
| Unknown Analyst | B. Riley Securities | $14.00 | Buy | +124.0% | Initiated | 07.08.26on TipRanks 10:08 | −7.4%next day −0.5% · 5 days −5.4% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $12.00 | Buy | +92.0% | Assigned | 07.08.26on TipRanks 07:26 | −7.4%next day −0.5% · 5 days −5.4% | ↗ |
| Ilya Zubkov★★★★★★★★★★#5009 · hits 59% · avg +9.5% | Freedom Capital Markets | $12.00 | Buy | +92.0% | Initiated | 07.04.26on TipRanks 05:10 | +6.9%next day −4.5% · 5 days −12.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Inogen
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $13.00 at a price of $5.27 (+146.7%); now: $13.00 at $6.25 (+108.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.14 (from $-0.17 to $-0.11). Last quarter: $-0.14.
Sales
Next quarter’s sales estimate — $92M (from $92M to $92M). Last quarter: $95M.
Best top-analyst consensus in the sector · Healthcare
About Inogen
- CEO: Kevin R. Smith
- Employees: 753
- 500 Cummings Center, Beverly, MA, 01915, US
- www.inogen.com
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Data from the stock’s TipRanks forecast page, read 18 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗